Fundraising FoxPierianDx
St. Louis, US · Founded 2015 · Delaware corporation · 3 known investors
Find your way into PierianDx
Sign up to see every warm intro you have to PierianDx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PierianDx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PierianDx was founded in 2015 by Rakesh Nagarajan.
Board
Investors · 3
How we know: board seat on SEC Form D · funding news · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$41.9M disclosed across 3 rounds · 2018–2021
▶$17MraisedNov 2021 · 13 investors · BiotechnologyRule 506(b)
- Kerry PropperDirector
- Barnard BuscemiDirector
- Mark McDonoughExecutive Officer, Director
- Rakesh NagarajanExecutive Officer, Director
- Joseph BooradyDirector
- Frederick HesslerDirector
- Bryan CareyDirector
- Offering amount
- $17M
- Amount sold
- $17M
- Minimum investment
- $50K
- Sales commissions
- $300K
- Placement agents
- Cowen and Company, LLC
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.9MraisedNov 2019 · 13 investors · BiotechnologyRule 506(b)
- Chris CallahanExecutive Officer
- James StarrExecutive Officer
- Michael SandersonExecutive Officer, Director
- Kerry PropperDirector
- Rakesh NagarajanExecutive Officer, Director
- Peter JobseDirector
- Frederick HesslerDirector
- Brian CareyDirector
- Charles BooradyDirector
- Offering amount
- $26.9M
- Amount sold
- $21.9M
- Minimum investment
- $50K
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3MraisedFeb 2018 · 4 investors · BiotechnologyRule 506(b)
- Rakesh NagarajanExecutive Officer, Director
- Frederick HesslerDirector
- Peter JobseDirector
- Charles BooradyDirector
- Reid RobisonDirector
- Brian CareyDirector
- Offering amount
- $5M
- Amount sold
- $3M
- Minimum investment
- $60K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Acquisitions · 1
Early investors' stakes continue via these dealsTute Genomics was a Provo, Utah-based bioinformatics company offering a cloud-based platform for analyzing and annotating whole genomes and exomes to support clinical and precision medicine research.
Frequently asked questions
- Who founded PierianDx?
- PierianDx was founded by Rakesh Nagarajan in 2015.
- Who are PierianDx's investors?
- PierianDx's investors include ATW Partners, Health Catalyst Capital, SJF Ventures.
- How much funding has PierianDx raised?
- PierianDx has disclosed $41.9M raised across 3 rounds.
- Where is PierianDx headquartered?
- PierianDx is headquartered in St. Louis, US.